Evidence map›Paper›PMID 15242947›Full record

ArticleClinical and diagnostic laboratory immunology2004

Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response.

Salma Al-Darmaki, Kandi Knightshead, Yuichi Ishihara, Al Best, Harvey A Schenkein, John G Tew, Suzanne E Barbour

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Clinical and diagnostic laboratory immunology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03492086 (Clinical Study to Evaluate the Effectiveness and Safety of the Consumption of a Food Supplement in a Group of Healthy People), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03492086 nacompletednot on this mapstarted 2015, after this paper: background citation

Clinical Study to Evaluate the Effectiveness and Safety of the Consumption of a Food Supplement in a Group of Healthy People

TypeinterventionalSponsorIMDEA FoodRan2015 to 2015Enrolled60ConditionsImmune System and Related DisordersArmsDietary supplementation with capsules containing rosemary and alkylglycerol, Dietary supplementation with control capsules
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Dendritic cells at the oral mucosal interface.Journal of dental research · 2006
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Salma Al-DarmakiClinical Research Center for Periodontal Diseases, Virginia Commonwealth University, Richmond, Virginia, USA.
Kandi Knightshead
Yuichi Ishihara
Al Best
Harvey A Schenkein
John G Tew
Suzanne E Barbour
Virginia Commonwealth University · US

Funding

PAF ACETYL-HYDROLASE IN LOCALIZED JUVENILE PERIODONTITISP01DE013102 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI SCHENKEIN, HARVEY ALLEN · 2002 to 2004
$4.7M
PAF ACETYL-HYDROLASE IN LOCALIZED JUVENILE PERIODONTITISU19DE013102 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI SCHENKEIN, HARVEY ALLEN · 2000 to 2001
$1.9M
NIDCR NIH HHS DE-13102NIDCR NIH HHS P01 DE013102NIDCR NIH HHS U19 DE013102
6 · The paper itself

Abstract

Localized aggressive periodontitis (LAgP) is a chronic inflammatory disease characterized by severe destruction of periodontal tissues surrounding the first molars and incisors. LAgP subjects produce large amounts of immunoglobulin G2 (IgG2) antibody against oral pathogens, and this response is inversely correlated with the severity of disease. We previously demonstrated that platelet-activating factor (PAF) is required for optimal IgG2 responses. The present investigation was designed to determine the mechanism of IgG2 induction by PAF. Exogenous PAF acetylhydrolase suppressed approximately 80% of pokeweed mitogen-stimulated IgG2 production, confirming that PAF is essential for optimal responses. PAF-activated leukocytes produced gamma interferon (IFN-gamma), a Th1 cytokine that has been associated with IgG2 responses in previous studies. The monocyte-derived cytokines interleukin-12 (IL-12) and IL-18 are upstream of IFN-gamma production, and IgG2 production was suppressed by neutralizing antibodies against these proteins. In addition, PAF induced monocyte-derived dendritic cells (DC) but not macrophages (MPhi) to secrete IL-12 and IL-18. This observation was interesting because monocyte differentiation in LAgP subjects is skewed to the DC phenotype. Although other investigators have implicated IFN-gamma in IgG2 production, its precise role in this response is controversial. Our studies suggest that IFN-gamma induces isotype switching to IgG2 but only in concert with the Th2 cytokine IL-4. Thus, it appears that the unique PAF metabolism of LAgP monocytes or DC promotes Th1 responses that are essential for optimal IgG2 antibody production. As IgG2 antibodies opsonize oral bacteria and promote their clearance and destruction, these alterations in PAF metabolism may be essential for limiting disease severity in LAgP patients.

Indexed as

1-Alkyl-2-acetylglycerophosphocholine EsteraseAdultB-LymphocytesCytokinesDendritic CellsHumansImmunoglobulin Class SwitchingImmunoglobulin GInterferon-gammaInterleukin-4In Vitro TechniquesLeukocytesLymphocyte ActivationMacrophagesPeriodontal DiseasesPlatelet Activating Factor1-Alkyl-2-acetylglycerophosphocholine EsteraseCytokinesImmunoglobulin GInterferon-gammaInterleukin-4Platelet Activating Factor

Identifiers

PMID15242947
PMCPMC440608
OpenAlexW2171713866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.